Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Kidney International|April 23, 2002
Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expressionJohn Kanellis, Kathy Paizis, Alison J Cox, et al.
Kidney International|August 2, 2013
AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patientsKevin J Martin, Karen Pickthorn, Saling Huang, et al.
The Biochemical Journal|March 8, 2007
Regulation of the renal-specific Na+-K+-2Cl- co-transporter NKCC2 by AMP-activated protein kinase (AMPK)Scott A Fraser, Ignacio Gimenez, Natasha Cook, et al.
Nephron. Physiology|October 26, 2005
Phosphorylation of neuronal and endothelial nitric oxide synthase in the kidney with high and low salt dietsPeter F Mount, Scott A Fraser, Yasuo Watanabe, et al.
Nephron. Physiology|January 31, 2004
A study of VEGF and its receptors in two rat models of proteinuriaJohn Kanellis, Vicki Levidiotis, Tiffany Khong, et al.
Scientific Reports|February 14, 2019
Three Dimensional Glomerular Reconstruction: A Novel Approach to Evaluate Renal Microanatomy in Diabetic Kidney DiseaseNiloufar Torkamani, George Jerums, Paul Crammer, et al.
Immunology and Cell Biology|January 13, 2006
Activators of the energy sensing kinase AMPK inhibit random cell movement and chemotaxis in U937 cellsJohn Kanellis, Rangi K Kandane, Dariush Etemadmoghadam, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2018
Diagnostic application of kidney allograft-derived absolute cell-free DNA levels during transplant dysfunctionJohn B Whitlam, Ling Ling, Alison Skene, et al.
Immunology and Cell Biology|April 21, 2010
5-aminoimidazole-4-carboxamide ribonucleoside and AMP-activated protein kinase inhibit signalling through NF-κBMarina Katerelos, Stuart J Mudge, David Stapleton, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Blocking AMPK signalling to acetyl-CoA carboxylase increases cisplatin-induced acute kidney injury and suppresses the benefit of metforminGeoff Harley, Marina Katerelos, Kurt Gleich, et al.
Pageof 7